sars-cov-2 variant (omicron ba.5) mrna vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 16, 2022 (NCT05550142)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05549206 | N/A | Feb 28, 2023 | AIM Therapeutics Inc., Bengbu Medical College, Government of China |
| NCT05745545 | N/A | Jan 4, 2023 | AIM Therapeutics Inc., Bengbu Medical College, Government of China |
| NCT05550142 | N/A | Sep 16, 2022 | AIM Therapeutics Inc., Bengbu Medical College, Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AIM Therapeutics Inc. | For profit | 3 | 0 | 1 | 2022 |
| Bengbu Medical College | Academic/Hospital | 3 | 0 | 1 | 2022 |
| Government of China | Government | 3 | 3 | 1 | 2022 |
3 organizations
Page 1 / 1